75 Years Old and More, Cancer, Chemotherapy
Conditions
Keywords
cancer, chemotherapy
Brief summary
Many cancers are diagnosed after 75 years. Treatment in chemotherapy begins without evidence of geriatric risk factors. A new tool for screening for geriatric fragilities is used, a self-administered questionnaire carried out by the patient before each chemotherapy cure. The objective is to secure the quality of patient care and to detect the appearance and / or aggravation of geriatric fragilities.
Detailed description
Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment: * Number of D-FOGs filled in: comparison with the number of patients included in the study and the number of visits of each patient. * Regularity of the D-FOG self-questionnaire by the patient: comparison with the number of visits of the patient for a chemotherapy cure (HDJ or HDS). * Number of criteria entered by D-FOG: comparison with the total number of criteria to be filled in * Criterion analysis of D-FOG
Interventions
OTHERSelf-questionnaire
Filling of a self-questionnaire before each chemotherapy cure
Sponsors
Poitiers University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients aged 75 years and over * Carriers of diagnosed cancer (excluding hematology) * Whatever the location, uniqueness or multiple, duration of development and treatment status (adjuvant, neoadjuvant, locally advanced or metastatic) * Seen in nursing consultant * Beginning an oncological treatment * Supported for oncology day hospital (HDJ) or weekly (HDS) chemotherapy * Patient not opposed to participate in the study
Exclusion criteria
* Patients under 75 years of age * Having not had an IDE ad consultation * During oncological treatment * Receiving Oral Therapy or hormone therapy alone * Treated by radiotherapy alone or surgery alone * Not attending a day or week oncology hospital * Refusal to participate in research
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment. | 3 months | Feasibility of D-FOG for patients : number of D-FOGs filled in, regularity of the D-FOG self-questionnaire by the patient, number of criteria entered by D-FOG, criterion analysis of D-FOG |
Countries
France
Outcome results
None listed